ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $846,149 | -2.4% | 12,599 | -1.6% | 0.01% | 0.0% |
| Q2 2023 | $866,553 | +21.6% | 12,798 | -2.8% | 0.01% | +20.0% |
| Q1 2023 | $712,497 | -9.1% | 13,170 | +0.5% | 0.01% | -23.1% |
| Q4 2022 | $783,750 | +47.6% | 13,104 | +11.7% | 0.01% | +30.0% |
| Q3 2022 | $531,000 | -20.2% | 11,729 | -1.2% | 0.01% | -23.1% |
| Q2 2022 | $665,000 | -43.4% | 11,867 | -28.1% | 0.01% | -35.0% |
| Q1 2022 | $1,174,000 | +7.7% | 16,504 | -1.2% | 0.02% | +17.6% |
| Q4 2021 | $1,090,000 | -14.0% | 16,709 | -1.1% | 0.02% | -29.2% |
| Q3 2021 | $1,268,000 | -5.6% | 16,897 | -1.8% | 0.02% | -4.0% |
| Q2 2021 | $1,343,000 | +8.3% | 17,213 | +13.7% | 0.02% | -3.8% |
| Q1 2021 | $1,240,000 | -0.4% | 15,135 | +0.5% | 0.03% | -3.7% |
| Q4 2020 | $1,245,000 | +27.4% | 15,057 | +0.2% | 0.03% | +12.5% |
| Q3 2020 | $977,000 | +17.4% | 15,032 | +11.8% | 0.02% | +14.3% |
| Q2 2020 | $832,000 | – | 13,441 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |